Suggestions
Elisabetta Cribioli
Tumor Immunologist specialized in CAR T cells therapies at Ludwig Cancer Research Center
Elisabetta Cribioli is a Tumor Immunologist specializing in CAR T cell therapies, currently working as a Process Development Scientist in T cell therapy at the CHUV Cell Manufacturing Facility, which is part of the Lausanne University Hospital (CHUV).1
Her professional background includes:
Expertise
- Tumor Immunology
- CAR T cell therapies
- Process Development in T cell therapy
Current Position
- Process Development Scientist
- T cell therapy division
- CHUV Cell Manufacturing Facility
- CHUV | Lausanne University Hospital
Previous Experience
Elisabetta has previously worked at the Ludwig Cancer Research Center, where she focused on CAR T cell therapies.1 Her work has contributed to advancements in the field of cancer immunotherapy, particularly in the development and application of CAR T cell treatments.
Research Contributions
Cribioli has been involved in significant research projects. One of her works, which was published in Nature, received recognition from colleagues in the field.2 This suggests that her research has made important contributions to the understanding and development of cancer therapies.
Professional Network
Elisabetta Cribioli has established a substantial professional network, with over 500 connections on LinkedIn.1 This extensive network likely reflects her active engagement in the scientific community and her collaborations with other researchers and professionals in her field.
Elisabetta Cribioli's career demonstrates a strong focus on cutting-edge cancer therapies, particularly in the realm of T cell-based treatments. Her work at the intersection of tumor immunology and cell therapy development positions her as a key contributor to advancements in personalized cancer treatments.
